Laurus Global Equity Management Inc. increased its position in shares of Integer Holdings Corporation (NYSE:ITGR – Free Report) by 14.9% in the 2nd quarter, HoldingsChannel reports. The firm owned 54,910 shares of the medical equipment provider’s stock after acquiring an additional 7,140 shares during the quarter. Integer accounts for 4.4% of Laurus Global Equity Management Inc.’s portfolio, making the stock its 8th largest holding. Laurus Global Equity Management Inc.’s holdings in Integer were worth $6,752,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of the company. Opal Wealth Advisors LLC acquired a new position in shares of Integer in the 1st quarter valued at approximately $28,000. Bessemer Group Inc. increased its stake in Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 125 shares during the last quarter. SVB Wealth LLC acquired a new position in Integer during the first quarter valued at approximately $35,000. GAMMA Investing LLC lifted its stake in Integer by 20.2% during the second quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider’s stock worth $98,000 after purchasing an additional 134 shares during the last quarter. Finally, Headlands Technologies LLC boosted its holdings in shares of Integer by 1,234.8% in the 1st quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider’s stock valued at $145,000 after purchasing an additional 1,136 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have recently commented on ITGR. Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a report on Saturday, September 27th. Raymond James Financial decreased their target price on Integer from $150.00 to $143.00 and set an “outperform” rating on the stock in a research report on Friday, July 25th. Truist Financial dropped their target price on shares of Integer from $145.00 to $137.00 and set a “buy” rating for the company in a report on Friday, July 25th. Wall Street Zen upgraded shares of Integer from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Finally, Wells Fargo & Company lowered their price objective on shares of Integer from $152.00 to $132.00 and set an “overweight” rating for the company in a research report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Integer currently has an average rating of “Moderate Buy” and a consensus target price of $139.57.
Integer Stock Performance
Integer stock opened at $105.21 on Monday. The business has a 50 day moving average of $105.65 and a 200-day moving average of $114.03. The company has a market capitalization of $3.69 billion, a P/E ratio of 46.35, a P/E/G ratio of 0.83 and a beta of 0.97. Integer Holdings Corporation has a 1 year low of $99.73 and a 1 year high of $146.36. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18.
Integer (NYSE:ITGR – Get Free Report) last posted its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.02). Integer had a return on equity of 12.27% and a net margin of 4.61%.The business had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. During the same period in the previous year, the firm earned $1.30 earnings per share. The company’s revenue was up 11.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, equities research analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.
About Integer
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Read More
- Five stocks we like better than Integer
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Cybersecurity Stocks Poised for Long-Term Growth
- ESG Stocks, What Investors Should Know
- 3 Defense Stocks Surging as Ukraine Tensions Deepen
- Roth IRA Calculator: Calculate Your Potential Returns
- Starbucks Stock Slumps; This Competitor Shows Strength
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.